← Back

Assure Tech Hangzhou Co Ltd

Assure Tech (Hangzhou) Co., Ltd. researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. Its activities include POCT and plastic product manufacturing, online sales, pharmaceutical manufacturing and sales, and medical testing. The company offers tests for drug of abuse, infectious disease, fertility, cardiac markers, tumor markers, allergens, and veterinary use, as well as biochemistry, chronic disease monitoring systems, and readers and analyzers. It also provides infectious disease, fertility, fecal occult blood, and vaginal pH tests. Founded in 2008, it is based in Hangzhou, China.

Price · split & dividend adjusted
News & notes moving 688075.CG
688075.CG2

Assure Tech posts net loss of 10.64 million yuan in 2026 interim report

Assure Tech released its 2026 interim report, showing a swing from profit to loss, with net profit attributable to the parent company at negative 10.64 million yuan, a decrease of 69.95 million yuan from the same period last year, down 117.94 percent year on year. Total operating revenue was 189 million yuan, down 17.80 percent year on year. Net cash flow from operating activities was negative 35.52 million yuan, down 1,109.59 percent year on year. The company's gross margin was 44.61 percent, return on equity was negative 0.21 percent, and diluted earnings per share was negative 0.08 yuan.
Jiemian·22dRead more →